Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Halohydrin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced patent-based process for trifluoromethylated halohydrins. Enhances purity and supply chain reliability for pyrethroid acid manufacturing.
Patent CN1819998B details a novel route for epoxy alcohol intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN117568294A reveals P450 mutant for S-halohydrins. Offers green synthesis and supply chain stability for pharma intermediates.
Discover the CN110699345A patent technology for enhanced stereoselectivity in chiral epoxide synthesis. Reliable supplier for pharmaceutical intermediates with cost-effective biocatalytic solutions.
Novel halohydrin route for Entecavir intermediate N4 avoids hazardous epoxidation, offering safer scale-up and cost efficiency for antiviral manufacturing.
Novel patent CN114671782A details a scalable synthesis of chiral halohydrin amines from L-phenylalanine, offering high purity and cost-effective manufacturing for antiviral intermediates.
Patent CN104673733B reveals a novel HHDH enzyme route for high-purity statin intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN1066728C reveals a robust 3-step route for epoxide intermediates, offering significant cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Patent CN113930415A details a novel enzymatic route for antifungal intermediates, offering high stereoselectivity and simplified purification for scalable manufacturing.